Want to see SINT full AI Analyst Report?
SINT Stock Chart & Stats
$3.74
-$0.35(-9.09%)
At close: 4:00 PM EST
$3.74
-$0.35(-9.09%)
Day’s Range― - ―
52-Week Range$1.40 - $6.78
Previous CloseN/A
Volume24.46K
Average Volume (3M)148.79K
Market Cap
$9.92M
Enterprise Value$9.26
Total Cash (Recent Filing)$1.89M
Total Debt (Recent Filing)$3.26M
Price to Earnings (P/E)―
Beta2.62
Next Earnings
Aug 11, 2026EPS Estimate
-0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.63
Shares Outstanding6,357,630
10 Day Avg. Volume107,243
30 Day Avg. Volume148,787
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.66
Price to Sales (P/S)10.52
P/FCF Ratio-1.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$8.00Price Target Upside113.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-2.14
Revenue Forecast (FY)$2.04M
Bulls Say, Bears Say
Bulls Say
Proprietary Silicon Nitride TechnologySintx’s proprietary silicon nitride material is a durable fundamental asset: the specialty ceramic has distinct performance attributes for medical implants and adjacent industrial uses, providing a structural product moat and long‑term differentiation that supports commercialization and licensing paths.
Recent Financing Bolstered LiquidityThe ~$5.0M of recent capital (private placement plus ATM) materially extends near‑term runway, funds commercialization and business development, and reduces immediate refinancing pressure, giving management time to execute commercialization milestones and de‑risk tech adoption.
Capital‑structure Actions To Improve EquityThe warrant conversion and reissuance program and pre‑funded warrants clarify the cap table and aim to shore up reported equity. Structural cap‑table remediation can reduce overhang, enable clearer financing plans and improve investor confidence if tied to durable operational improvements.
Bears Say
Severe Cash BurnSustained negative operating and free cash flow near -$10M TTM is a structural risk: it consumes balance‑sheet resources, forces recurring financings or dilutive instruments, and constrains long‑term investment in commercialization, making consistent execution and scale challenging.
Very Small Revenue And Negative Gross MarginA tiny revenue base combined with a negative gross margin indicates product economics are not proven and fixed costs overwhelm sales. This weak operating leverage limits the company's ability to absorb R&D and commercialization expenses and lengthens the path to sustainable profitability.
Equity Erosion And Listing NoncomplianceSeverely eroded equity (≈$904k) and rising leverage raise balance‑sheet fragility and triggered a Nasdaq notice. This structural governance and listing risk increases urgency for dilutive financing, adds execution pressure, and may constrain strategic options if compliance is not restored.
Sintx Technologies News
SINT FAQ
What was Sintx Technologies Inc’s price range in the past 12 months?
Sintx Technologies Inc lowest stock price was $1.40 and its highest was $6.78 in the past 12 months.
What is Sintx Technologies Inc’s market cap?
Sintx Technologies Inc’s market cap is $9.92M.
When is Sintx Technologies Inc’s upcoming earnings report date?
Sintx Technologies Inc’s upcoming earnings report date is Aug 11, 2026 which is in 11 days.
How were Sintx Technologies Inc’s earnings last quarter?
Sintx Technologies Inc released its earnings results on Nov 13, 2025. The company reported -$3.46 earnings per share for the quarter, missing the consensus estimate of -$0.55 by -$2.91.
Is Sintx Technologies Inc overvalued?
According to Wall Street analysts Sintx Technologies Inc’s price is currently Undervalued.
Does Sintx Technologies Inc pay dividends?
Sintx Technologies Inc does not currently pay dividends.
What is Sintx Technologies Inc’s EPS estimate?
Sintx Technologies Inc’s EPS estimate is -0.73.
How many shares outstanding does Sintx Technologies Inc have?
Sintx Technologies Inc has 6,357,630 shares outstanding.
What happened to Sintx Technologies Inc’s price movement after its last earnings report?
Sintx Technologies Inc reported an EPS of -$3.46 in its last earnings report, missing expectations of -$0.55. Following the earnings report the stock price went down -10.787%.
Which hedge fund is a major shareholder of Sintx Technologies Inc?
Currently, no hedge funds are holding shares in SINT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sintx Technologies Inc
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
SINT Stock 12 Month Forecast
Average Price Target
$8.00
▲(113.90% Upside)
Technical Analysis
Strata Skin Sciences
―
Solana Company
―
Vyome Holdings
―
Co-Diagnostics
―
Tenon Medical, Inc.
―
Ownership Overview
4.20% Insiders
0.72% Mutual Funds
0.16% Other Institutional Investors
94.51% Public Companies and
Individual Investors